WuXi STA and Antengene Sign Development and Manufacturing Agreement

Jul 20, 2018

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Antengene Corporation, a biopharmaceutical company, recently announced a strategic partnership for the CMC development and manufacturing of innovative oncology drugs. Under the terms of the collaboration, WuXi STA will provide Antengene an integrated solution in process R&D and manufacturing, using the MAH scheme to accelerate new drug development. Antengene is a biopharmaceutical company focused on the development of new drugs in China and the Asia-Pacific region. Through both internal research & development as well as external partnership, Antengene strives to bring cutting-edge innovative therapies to patients. ...

Read More

Plasticell leads gene therapy manufacturing consortium with Great Ormond Street Hospital and UCL Institute of Child Health: UK’s innovation agency provides funding to develop advanced technologies for the manufacturing of autologous ex vivo gene therapies

Jun 26, 2018

Plasticell, a developer of stem cell technologies and therapies, has announced it is leading a consortium of pioneering gene therapy groups at UCL’s Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) to develop advanced technologies for the manufacturing of ex vivo gene therapies. The initial focus is on rare inherited disorders of the immune system including Chronic Granulomatous Disease. “There are a number of highly promising gene therapy targets currently under investigation globally but in order to commercialise these potential cures, the industry urgently needs to find better ways of manufacturing therapeutic products. It is a really ...

Read More

CPhI report predicts new finished product manufacturing hub in the Middle East

May 31, 2018

Forgotten markets of Africa and Arabia to see increased growth fuelled by international & domestic partnerships and imported APIs A new report by CPhI forecasts sizable changes ahead for the pharma markets in the Middle East and Africa over the next few years. It highlights recent regulatory changes, coupled with increased geopolitical stability and rising generics consumption as key drivers in transforming the prospects of pharma manufacturers in the region. The CPhI Middle East and Africa report – released ahead of the inaugural edition of CPhI MEA (03-05 September 2018, Abu Dhabi) – has identified significant opportunities for a region ...

Read More

Almac Group Appoints David Taylor as Head of Manufacturing Operations

May 1, 2018

David Taylor joined the Almac Group in November 2017 as Head of Manufacturing, Almac Sciences.  He is tasked with the overall accountability for small molecule API and peptide manufacturing in Craigavon, and delivering on Almac’ Sciences’ supply chain operations at the Northern Ireland site.  David has worked in the pharmaceutical and fine chemical industries for over twenty-two years, and brings with him a strong background in both the technical and manufacturing disciplines, allowing him to lead multidisciplinary teams to deliver streamlined operational outcomes. In an industry with significant emphasis on safety, quality and regulatory compliance, David has the skill set ...

Read More

Phoenix Molecular Designs Announces Manufacturing Collaboration with WuXi STA to advance PMD-026 toward IND

Apr 18, 2018

MD-026 is the first RSK inhibitor to demonstrate potential disease-modifying properties in triple-negative breast cancer (TNBC)   Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced that it has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026 needed for IND-enabling toxicology studies and a Phase I study in women.   Under the terms of the collaboration agreement, STA will become a new manufacturing partner for PhoenixMD for their platform of kinase inhibitor drug candidates to treat a wide range of unmet ...

Read More